http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106978507-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate | 2017-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106978507-B |
| titleOfInvention | Diagnosis of glaucoma molecular marked compound lncRNAsENST00000508241, kit and application |
| abstract | The invention discloses molecular marked compound lncRNAs ENST00000508241, kit and the applications for diagnosis of glaucoma.It is found by the applicant that relative to control group crowd, lncRNAs:ENST00000508241 up-regulated expressions in the aqueous humor of glaucoma patient.Prompt ENST00000508241 is the high expression lncRNAs in glaucoma, contributes to the biomarker of diagnosis of glaucoma.The present invention provides strong molecular biology mechanism for diagnosis of glaucoma, has far-reaching clinical meaning and generalization. |
| priorityDate | 2017-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.